1. Preventing the induction of acid saline-induced fibromyalgia pain in mice by electroacupuncture or APETx2 injection
- Author
-
Ching Liang Hsieh, Hsin-Cheng Hsu, Liang-Ta Yen, and Yi Wen Lin
- Subjects
Fibromyalgia ,dorsal root ganglion ,Electroacupuncture ,medicine.medical_treatment ,Thalamus ,acid-sensing ion channel ,Mice ,Dorsal root ganglion ,thalamus ,Acupuncture ,medicine ,Animals ,Pain Management ,Saline ,business.industry ,Chronic pain ,spinal cord ,General Medicine ,medicine.disease ,Spinal cord ,Combined Modality Therapy ,Original Papers ,Acid Sensing Ion Channels ,Disease Models, Animal ,medicine.anatomical_structure ,Complementary and alternative medicine ,Acid Sensing Ion Channel Blockers ,Hyperalgesia ,Anesthesia ,fibromyalgia pain ,Female ,Neurology (clinical) ,business ,sodium channel - Abstract
Background: Fibromyalgia (FM) is a syndrome involving chronic pain, fatigue, sleep difficulties, morning stiffness and muscle cramping lasting longer than 3 months. The epidemiological prevalence is approximately 3–5% in women and increases with age. Antagonism of acid-sensing ion channel 3 (ASIC3) reportedly attenuates acid saline-induced FM pain in mice. Aims: Whether pre-treatment with electroacupuncture (EA) or APETx2 can attenuate mechanical hyperalgesia in this murine model remains unknown. Methods: Accordingly, we examined the analgesic effect of EA in a murine model of FM pain induced by dual injections of acid saline and investigated whether EA or APETx2 can attenuate FM pain via the ASIC3 channel. Results: EA significantly reduced mechanical hyperalgesia in this model. ASIC3 antagonism, induced by injecting APETx2, also significantly reduced mechanical hyperalgesia. The expression of ASIC3 in the dorsal root ganglia, spinal cord and thalamus was increased after FM model induction. Over-expression of these nociceptive channels was attenuated by pre-treatment with EA or an ASIC3 antagonist. Conclusion: Our data reveal that both EA and ASIC3 blockade significantly reduce FM pain in mice via the ASIC3, Nav1.7 and Nav1.8 signalling pathways. Moreover, our findings support the potential clinical use of EA for the treatment of FM pain.
- Published
- 2020